Table 1.
Mean ±s.d. haemoglobin, haematocrit and systolic and diastolic blood pressure responses in the control and RhEPO treatment groups
| Baseline | Baseline | Week 1 | Week 2 | Week 3 | Week 4 | Post |
|---|---|---|---|---|---|---|
| Control [Hb] (g dl−1) | 16.0 ± 0.7 | 15.9 ± 0.5 | 15.7 ± 0.8 | 15.7 ± 0.5 | 15.7 ± 0.6 | 15.5 ± 1.1 |
| Control Hct (%) | 43 ± 3 | 44 ± 1 | 45 ± 2 | 44 ± 2 | 44 ± 3 | 44 ± 3 |
| Control BP Sys (mmHg) | 125 ± 7 | 122 ± 9 | 124 ± 7 | 124 ± 8 | 123 ± 7 | 126 ± 7 |
| Control BP Dia (mmHg) | 73 ± 7 | 77 ± 11 | 77 ± 10 | 78 ± 10 | 77 ± 9 | 83 ± 9 |
| RhEPO [Hb] (g dl−1) | 15.8 ± 1.0 | 16.1 ± 1.4 | 16.3 ± 0.9 | 16.8 ± 0.7 * | 16.9 ± 0.7 * | 16.8 ± 0.9* |
| RhEPO Hct (%) | 43 ± 3 | 45 ± 3 | 46 ± 2 | 48 ± 1 * | 49 ± 2 * | 48 ± 2* |
| RhEPO BP Sys (mmHg) | 128 ± 6 | 126 ± 8 | 125 ± 10 | 124 ± 11 | 126 ± 12 | 123 ± 13 |
| RhEPO BP Dia (mmHg) | 76 ± 6 | 79 ± 8 | 81 ± 9 | 82 ± 9 | 82 ± 9 | 85 ± 9 |
*
Significantly different from the corresponding control value and to RhEPO baseline (P < 0.01); BP Sys, systolic blood pressure; BP Dia, diastolic blood pressure.